Editorial: Roles of Tumor-Recruited Myeloid Cells in Immune Evasion in Cancer.
| Autor: | Kusmartsev S; Department of Urology, University of Florida, Gainesville, FL, United States., Serafini P; Department of Microbiology and Immunology, University of Miami, Miami, FL, United States., Bharadwaj SN; Department of Internal Medicine, University of South Florida, Tampa, FL, United States., Kortylewski M; Department of Immuno-Oncology, Beckman Research Institute at City of Hope Comprehensive Cancer Center, Duarte, CA, United States. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in immunology [Front Immunol] 2021 Aug 27; Vol. 12, pp. 749605. Date of Electronic Publication: 2021 Aug 27 (Print Publication: 2021). |
| DOI: | 10.3389/fimmu.2021.749605 |
| Abstrakt: | Competing Interests: SK is a founder of the K-Lab Therapeutics. PS is a founder and shareholder of ABTvax. MK is a founder of iSTAT Therapeutics and a scientific advisor to Scopus Biopharma. MK is a co-founder of Duet Therapeutics, shareholder and scientific advisor to Scopus Biopharma. PS is co-founder of ABTvax and scientific founder of Wink therapeutics. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|